GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.
Frequently asked questions
What sector does GemVax&KAEL Co.Ltd (082270) operate in?
GemVax&KAEL Co.Ltd belongs to the Information Technology sector and operates in the Semiconductors & Semiconductor Equipment industry.
What is GemVax&KAEL Co.Ltd (082270) current stock price?
As of the latest data, GemVax&KAEL Co.Ltd stock price is ₩12,030, with a previous close of ₩12,030.
What is GemVax&KAEL Co.Ltd (082270) current market capitalization?
GemVax&KAEL Co.Ltd market cap is approximately 429.14 billion.
Does GemVax&KAEL Co.Ltd (082270) pay dividends?
No. GemVax&KAEL Co.Ltd does not pay a dividend.
What is GemVax&KAEL Co.Ltd (082270) beta (volatility) score?
GemVax&KAEL Co.Ltd has a beta of 1.324, suggesting it is more volatile than the market.
